Short report: Persistence of tumor necrosis factor-α in situ after lesion healing in mucosal leishmaniasis

21Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Mucosal leishmaniasis (ML) is a disease characterized by intense activation of inflammatory cells and extensive tissue destruction. Among the cytokines involved in the immune response to ML, tumor necrosis factor-α (TNF-α) has attracted strong interest because of its roles in the modulation of the immune response. We studied 20 patients with ML who provided biopsy specimens before treatment and after lesion healing obtained by specific therapy. The biopsy specimens were subjected to immunohistochemical analysis for in situ quantification of cellular and extracellular TNF-α. The amount of TNF-α was significantly lower in the healed lesions compared with pretreatment biopsy specimens, although TNF-α persisted at the tissue level even after lesion healing. This relevant finding demonstrates for the first time an in situ tissue reduction of TNF-α after treatment and shows persistence of TNF-α in healed lesions may be related to the maintenance of an immunopathologic background for relapses observed in ML.

Cite

CITATION STYLE

APA

Amato, V. S., Andrade, H. F., Neto, V. A., & Duarte, M. I. S. (2003). Short report: Persistence of tumor necrosis factor-α in situ after lesion healing in mucosal leishmaniasis. American Journal of Tropical Medicine and Hygiene, 68(5), 527–528. https://doi.org/10.4269/ajtmh.2003.68.527

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free